ISTITUTO NAZ PER LE MALATTIE I has a total of 17 patent applications. Its first patent ever was published in 2004. It filed its patents most often in Italy, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets biotechnology, environmental technology and machines are IDAHO RES FOUNDATION, NAT INST OF PARASITIC DISEASES CHINESE CT FOR DISEASE CONTROL AND PREVENTION and INST FOR ENVIRONMENTAL HEALTH INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Italy | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | China | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Environmental technology | |
#3 | Machines | |
#4 | Measurement | |
#5 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Climate change adaptation technologies | |
#2 | Measuring microorganism processes | |
#3 | Unspecified technologies | |
#4 | Microorganisms | |
#5 | Peptides | |
#6 | Analysing materials | |
#7 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Umansky Samuil R | 8 |
#2 | Tomei Louis David | 8 |
#3 | Cannas Angela | 8 |
#4 | Poccia Fabrizio | 5 |
#5 | Agrati Chiara | 4 |
#6 | Casetti Rita | 4 |
#7 | Martini Federico | 4 |
#8 | Capobianchi Maria Rosaria | 3 |
#9 | Ippolito Giuseppe | 3 |
#10 | Melkonyan Hovsep | 3 |
Publication | Filing date | Title |
---|---|---|
WO2009037723A1 | Method for the generation and expansion of gamma/delta t regulatory cells, cells thus obtained and their uses | |
WO2009001392A1 | Gene codifying for ambra 1 protein which regulates autophagv and the development of the central nervous system | |
WO2006088895A2 | Compositions and methods for detecting pathogen specific nucleic acids in urine | |
WO2005014799A1 | Conditioned cell culture medium, method to obtain the same and use of it for maintenance, proliferation and differentiation of mammalian cells | |
WO2005015207A2 | Method and diagnostic tests based on flow cytometric analysis of antigen-specific t lymphocytes |